2008
DOI: 10.1080/03639040701484106
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Tailor-Made HPMC-Based Matrix Minitablets Comprising a Weakly Basic Drug Compound

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 15 publications
0
17
0
Order By: Relevance
“…Others have indicated that it is necessary to optimise the acidifier level and choice [44], with again the lower pK a , lower solubility fumaric acid seeming to have advantages in improving the extended delivery of dipyridamole over the more soluble, but less acidic succinic acid. The slower release of fumaric acid from the hydrophilic matrix relative to succinic acid, associated with its lower solubility in the buffer, meant it could sustain the low microenvironmental pH for a longer period against the challenge of ingressing pH 6.8 buffer [44].…”
Section: Acidic Ph Modifiers For Basic Drugsmentioning
confidence: 97%
See 1 more Smart Citation
“…Others have indicated that it is necessary to optimise the acidifier level and choice [44], with again the lower pK a , lower solubility fumaric acid seeming to have advantages in improving the extended delivery of dipyridamole over the more soluble, but less acidic succinic acid. The slower release of fumaric acid from the hydrophilic matrix relative to succinic acid, associated with its lower solubility in the buffer, meant it could sustain the low microenvironmental pH for a longer period against the challenge of ingressing pH 6.8 buffer [44].…”
Section: Acidic Ph Modifiers For Basic Drugsmentioning
confidence: 97%
“…The slower release of fumaric acid from the hydrophilic matrix relative to succinic acid, associated with its lower solubility in the buffer, meant it could sustain the low microenvironmental pH for a longer period against the challenge of ingressing pH 6.8 buffer [44].…”
Section: Acidic Ph Modifiers For Basic Drugsmentioning
confidence: 99%
“…The pH M can be modulated for drug dissolution as long as the pH modifier is present inside the solid dosage form [17,35,36]. Thus, evaluation of pH modifier release behaviors is crucial for thoroughly understanding the drug release mechanism from such pHmodulating systems.…”
Section: Ph M and Dissolution Behaviorsmentioning
confidence: 99%
“…Examples of these excipients are organic acids such as adipic, fumaric, tartaric and succinic acid, which can be used to increase the solubility of weak bases by decreasing the pH of the microenvironment (Gabr 1992;Siepe, Lueckel et al 2008), and basic excipients such as dicalcium phosphate (DCP), magnesium oxide (MgO) and magnesium hydroxide (Mg(OH) 2 ), used to increase the solubility of weak acids by increasing the pH of the microenvironment (Doherty and York 1989).…”
Section: Polymers For Sustained Drug-release Systemsmentioning
confidence: 99%